Arvinas, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ARVN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -88.9 M-95.4 M-59.1 M-30.4 M-69.2 M -254.1 M Cash from investing activities 69.5 M128.8 M63.5 M145.8 M13.7 M 351.8 M Cash from financing activities -100 K500 K-17.8 M-74 M-100 K -91.4 M Free cash flow -88.9 M-95.4 M-59.1 M-30.4 M-69.2 M -254.1 M

News

A Look At The Transformation Around Rigel Pharmaceuticals (NASDAQ:RIGL)

uniQure (QURE) Soars 78.4%: Is Further Upside Left in the Stock?

Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?

Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential (NASDAQ:GLUE)

These Analysts Increase Their Forecasts On Arvinas After Q1 Results - Arvinas (NASDAQ:ARVN), Pfizer (NYSE

Arvinas, Inc. (ARVN) Q1 2026 Earnings Call Transcript

Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability

Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates

Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates

Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Earnings Preview: ProQR (PRQR) Q1 Earnings Expected to Decline

Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?